Literature DB >> 8006596

Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes.

M C Coles1, D H Raulet.   

Abstract

A small subset of functionally active CD4+ CD8- thymocytes express the NK1.1 marker, as do most CD4-CD8- NK1.1+ thymocytes. Previous studies have failed to implicate a role for major histocompatibility complex (MHC) or related molecules in the selection of the CD4+ CD8- NK1.1+ subset. We report here that the development of most of these cells is sharply reduced in class I-deficient mice, but not in class II-deficient mice. Hence, some CD4+ T cells are class I dependent and not class II dependent. Unlike conventional T cells, however, the development of NK1.1+ thymocytes in both the CD4+ CD8- and CD4- CD8- subsets is dependent on class I MHC expression by hematopoietic cells and not thymic epithelial cells. We propose that these populations are selected by nonpolymorphic class Ib or CD1 molecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006596      PMCID: PMC2191548          DOI: 10.1084/jem.180.1.395

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4.

Authors:  A Zlotnik; D I Godfrey; M Fischer; T Suda
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  M J Grusby; R S Johnson; V E Papaioannou; L H Glimcher
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

3.  Establishment of monoclonal anti-Nk-1.1 antibody.

Authors:  G C Koo; J R Peppard
Journal:  Hybridoma       Date:  1984

4.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  NK1.1+ thymocytes. Adult murine CD4-, CD8- thymocytes contain an NK1.1+, CD3+, CD5hi, CD44hi, TCR-V beta 8+ subset.

Authors:  Z K Ballas; W Rasmussen
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

6.  Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells.

Authors:  M Zijlstra; M Bix; N E Simister; J M Loring; D H Raulet; R Jaenisch
Journal:  Nature       Date:  1990-04-19       Impact factor: 49.962

7.  The fate of CD4-8- T cell receptor-alpha beta+ thymocytes.

Authors:  H I Levitsky; P T Golumbek; D M Pardoll
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

8.  Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage.

Authors:  Y Takahama; A Kosugi; A Singer
Journal:  J Immunol       Date:  1991-02-15       Impact factor: 5.422

9.  Positive selection of V beta 8+ CD4-8- thymocytes by class I molecules expressed by hematopoietic cells.

Authors:  M Bix; M Coles; D Raulet
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes.

Authors:  R C Budd; G C Miescher; R C Howe; R K Lees; C Bron; H R MacDonald
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  42 in total

1.  Natural killer 1.1(+) alpha beta T cells in the periimplantation uterus.

Authors:  Y Dang; J Beckers; C R Wang; K D Heyborne
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

2.  The differential effect of stress on natural killer T (NKT) and NK cell function.

Authors:  H Oya; T Kawamura; T Shimizu; M Bannai; H Kawamura; M Minagawa; H Watanabe; K Hatakeyama; T Abo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 3.  Innate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.

Authors:  Aleksandar K Stanic; Jang-June Park; Sebastian Joyce
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

Review 4.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

5.  The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.

Authors:  K Tamada; M Harada; O Ito; M Takenoyama; T Mori; G Matsuzaki; K Nomoto
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 6.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

7.  Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Authors:  Edward M Behrens; Scott W Canna; Katharine Slade; Sheila Rao; Portia A Kreiger; Michele Paessler; Taku Kambayashi; Gary A Koretzky
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

8.  CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes.

Authors:  M Exley; J Garcia; S B Wilson; F Spada; D Gerdes; S M Tahir; K T Patton; R S Blumberg; S Porcelli; A Chott; S P Balk
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

9.  Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.

Authors:  J C Guery; F Galbiati; S Smiroldo; L Adorini
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells.

Authors:  M Taniguchi; H Koseki; T Tokuhisa; K Masuda; H Sato; E Kondo; T Kawano; J Cui; A Perkes; S Koyasu; Y Makino
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.